Fina Dene is a modern hybrid that emerges from a complex genetic lineage consisting of Dragons Blood Hashplant, Afgooey, and White Cherry Truffle. As with many contemporary cannabis varieties, the specific origins and breeding history of Fina Dene remain undocumented, leaving its full developmental narrative unclear. The strain is well-suited for both indoor and outdoor cultivation, flowering over a 50-day period and offering a high yield for growers who possess a moderate level of experience.

The biochemical profile of Fina Dene is defined by a diverse range of terpenes, led by myrcene as the primary component, followed by pinene, caryophyllene, limonene, beta-pinene, ocimene, linalool, bisabolol, humulene, guaiol, and nerolidol. This arrangement provides a multifaceted sensory experience that reflects the contributions of its varied parentage. While its precise concentrations are not measured, the strain expresses a complex aromaticity influenced by this specific hierarchy of terpenes, anchoring its profile firmly in the earthier, resinous qualities of its hashplant ancestry combined with the sharper, lighter notes contributed by its other contributors.

Classified as a THC-dominant variety, Fina Dene is characterized by effects that are consistently reported as relaxed, happy, and uplifted. These attributes make it a functional choice for individuals seeking support with stress, pain, and sleep-related difficulties. With no notable offspring currently recorded in the registry, Fina Dene stands as a singular modern hybrid, offering a distinct cannabinoid and terpene impact for those focusing on its therapeutic potential and reliable cultivation cycle.